TITLE

5-ALPHA REDUCTASE INHIBITORS

PUB. DATE
January 2008
SOURCE
Complete Guide to Prescription & Nonprescription Drugs 2012;2008, p2
SOURCE TYPE
Encyclopedia
DOC. TYPE
Article
ABSTRACT
The article presents information on 5-Alpha Reductase Inhibitors, a drug used for treating noncancerous enlargement of the prostate gland in men and male pattern hair loss in men. The dosage and usage information is provided. The possible adverse reactions or side effects of the drug, warnings, and precautions are discussed. Possible interaction of the drug with other drugs is also mentioned.
ACCESSION #
31714880

 

Related Articles

  • 5-ALPHA REDUCTASE INHIBITORS.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2007, p2 

    The article presents information on 5-Alpha Reductase Inhibitors, a drug used for treating noncancerous enlargement of the prostate gland in men and male pattern hair loss in men. The dosage and usage information is provided. The possible adverse reactions or side effects of the drug, warnings,...

  • ALPHA ADRENERGIC RECEPTOR BLOCKERS. GRIFFITH, H. WINTER // Complete Guide to Prescription & Nonprescription Drugs 2012;2010, p20 

    The article presents information on alpha adrenergic receptor blockers, a drug developed to treat high blood pressure, Raynaud's disease and benign prostatic hyperplasia, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with...

  • JALYN.  // Monthly Prescribing Reference;Sep2010, Vol. 26 Issue 9, pA7 

    The article offers information on the drug Jalyn, a type I and II 5α-reductase inhibitor and α1A-blocker for benign prostatic hyperplasia (BPH) from GlaxoSmithKline. Jalyn works to reduce enlargement of the prostate gland. The article discusses clinical trials of the drug, along with...

  • dutasteride.  // Davis's Drug Guide for Nurses, 10th edition;2007, p440 

    The article presents a nursing guide to dutasteride, a benign prostatic hyperplasia agent. Indications and contraindications are mentioned. Adverse reactions to the drug are cited, including decreased libido and ejaculation disorders. Nursing implications and desired outcomes are provided. Drug...

  • JALYN.  // Nurse Practitioners Prescribing Reference;Winter2010/2011, Vol. 17 Issue 4, pA.16 

    The article offers information on the reductase inhibitor Jalyn, developed by GlaxoSmithKline which has the active ingredients dutasteride and tamsulosin and is used for the treatment of benign prostatic hyperplasia.

  • ANTIGLAUCOMA, CARBONIC ANHYDRASE INHIBITORS.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2008, p100 

    The article presents information on carbonic anhydrase inhibitors which are used for the treatment of glaucoma and ocular hypertension. The dosage and usage information is provided. The possible adverse reactions or side effects of the drug, warnings, and precautions are discussed. Possible...

  • EFLORNITHINE (Topical).  // Complete Guide to Prescription & Nonprescription Drugs 2012;2008, p348 

    The article presents information on eflornithine, a topical enzyme inhibitor used for the treatment of unwanted facial hair on women. The dosage and usage information is provided. The possible adverse reactions or side effects of the drug, warnings, and precautions are discussed. Possible...

  • ANTIGLAUCOMA, CARBONIC ANHYDRASE INHIBITORS. Griffits, H. Winter // Complete Guide to Prescription & Nonprescription Drugs 2012;2009, p100 

    The article presents information on carbonic anhydrase inhibitors, an antiglaucoma drug, including dosage, usage, adverse reactions, side effects, precautions, and possible interaction with other drugs.

  • TOLCAPONE. GRIFFITH, H. WINTER // Complete Guide to Prescription & Nonprescription Drugs 2012;2011, p804 

    The article presents information on tolcapone, an antidyskinetic used in combination with levodopa and carbidopa for the treatment of the symptoms of Parkinson's disease, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics